236 related articles for article (PubMed ID: 26818738)
1. De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures.
Fukai R; Saitsu H; Tsurusaki Y; Sakai Y; Haginoya K; Takahashi K; Hubshman MW; Okamoto N; Nakashima M; Tanaka F; Miyake N; Matsumoto N
J Hum Genet; 2016 May; 61(5):381-7. PubMed ID: 26818738
[TBL] [Abstract][Full Text] [Related]
2. Temple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity?
Mégarbané A; Al-Ali R; Choucair N; Lek M; Wang E; Ladjimi M; Rose CM; Hobeika R; Macary Y; Temanni R; Jithesh PV; Chouchane A; Sastry KS; Thomas R; Tomei S; Liu W; Marincola FM; MacArthur D; Chouchane L
BMC Med Genet; 2016 Jun; 17(1):42. PubMed ID: 27282200
[TBL] [Abstract][Full Text] [Related]
3. 'Splitting versus lumping': Temple-Baraitser and Zimmermann-Laband Syndromes.
Bramswig NC; Ockeloen CW; Czeschik JC; van Essen AJ; Pfundt R; Smeitink J; Poll-The BT; Engels H; Strom TM; Wieczorek D; Kleefstra T; Lüdecke HJ
Hum Genet; 2015 Oct; 134(10):1089-97. PubMed ID: 26264464
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy.
Simons C; Rash LD; Crawford J; Ma L; Cristofori-Armstrong B; Miller D; Ru K; Baillie GJ; Alanay Y; Jacquinet A; Debray FG; Verloes A; Shen J; Yesil G; Guler S; Yuksel A; Cleary JG; Grimmond SM; McGaughran J; King GF; Gabbett MT; Taft RJ
Nat Genet; 2015 Jan; 47(1):73-7. PubMed ID: 25420144
[TBL] [Abstract][Full Text] [Related]
5. De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia.
Fukai R; Saitsu H; Okamoto N; Sakai Y; Fattal-Valevski A; Masaaki S; Kitai Y; Torio M; Kojima-Ishii K; Ihara K; Chernuha V; Nakashima M; Miyatake S; Tanaka F; Miyake N; Matsumoto N
J Hum Genet; 2016 May; 61(5):451-5. PubMed ID: 26763878
[TBL] [Abstract][Full Text] [Related]
6. Patients with
Aubert Mucca M; Patat O; Whalen S; Arnaud L; Barcia G; Buratti J; Cogné B; Doummar D; Karsenty C; Kenis S; Leguern E; Lesca G; Nava C; Nizon M; Piton A; Valence S; Villard L; Weckhuysen S; Keren B; Mignot C
J Med Genet; 2022 May; 59(5):505-510. PubMed ID: 33811134
[TBL] [Abstract][Full Text] [Related]
7. Novel
von Wrede R; Jeub M; Ariöz I; Elger CE; von Voss H; Klein HG; Becker AJ; Schoch S; Surges R; Kunz WS
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33494179
[TBL] [Abstract][Full Text] [Related]
8. Potassium Voltage-Gated Channel Subfamily H Member 1 (KCNH1) Missense Mutation Causing Epileptic Encephalopathy And Autistic Behaviour.
Chand P; Sulaiman A; Kirmani S
J Pak Med Assoc; 2023 Sep; 73(9):1894-1896. PubMed ID: 37817707
[TBL] [Abstract][Full Text] [Related]
9. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome.
Kortüm F; Caputo V; Bauer CK; Stella L; Ciolfi A; Alawi M; Bocchinfuso G; Flex E; Paolacci S; Dentici ML; Grammatico P; Korenke GC; Leuzzi V; Mowat D; Nair LD; Nguyen TT; Thierry P; White SM; Dallapiccola B; Pizzuti A; Campeau PM; Tartaglia M; Kutsche K
Nat Genet; 2015 Jun; 47(6):661-7. PubMed ID: 25915598
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic expansion of KCNH1-associated disorders to include isolated epilepsy and its associations with genotypes and molecular sub-regional locations.
Tian MQ; Li RK; Yang F; Shu XM; Li J; Chen J; Peng LY; Yu XH; Yang CJ
CNS Neurosci Ther; 2023 Jan; 29(1):270-281. PubMed ID: 36285361
[TBL] [Abstract][Full Text] [Related]
11. Potassium Channel KCNH1 Activating Variants Cause Altered Functional and Morphological Ciliogenesis.
Napoli G; Panzironi N; Traversa A; Catalanotto C; Pace V; Petrizzelli F; Giovannetti A; Lazzari S; Cogoni C; Tartaglia M; Carella M; Mazza T; Pizzuti A; Parisi C; Caputo V
Mol Neurobiol; 2022 Aug; 59(8):4825-4838. PubMed ID: 35639255
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy in KCNH1-related syndromes.
Mastrangelo M; Scheffer IE; Bramswig NC; Nair LD; Myers CT; Dentici ML; Korenke GC; Schoch K; Campeau PM; White SM; Shashi V; Kansagra S; Van Essen AJ; Leuzzi V
Epileptic Disord; 2016 Jun; 18(2):123-36. PubMed ID: 27267311
[TBL] [Abstract][Full Text] [Related]
14. Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K
Gripp KW; Smithson SF; Scurr IJ; Baptista J; Majumdar A; Pierre G; Williams M; Henderson LB; Wentzensen IM; McLaughlin H; Leeuwen L; Simon MEH; van Binsbergen E; Dinulos MBP; Kaplan JD; McRae A; Superti-Furga A; Good JM; Kutsche K
Eur J Hum Genet; 2021 Sep; 29(9):1384-1395. PubMed ID: 33594261
[TBL] [Abstract][Full Text] [Related]
15. Kv10.1 potassium channel: from the brain to the tumors.
Cázares-Ordoñez V; Pardo LA
Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
[TBL] [Abstract][Full Text] [Related]
16. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental and Epilepsy Phenotypes in Individuals With Missense Variants in the Voltage-Sensing and Pore Domains of
Happ HC; Sadleir LG; Zemel M; de Valles-Ibáñez G; Hildebrand MS; McConkie-Rosell A; McDonald M; May H; Sands T; Aggarwal V; Elder C; Feyma T; Bayat A; Møller RS; Fenger CD; Klint Nielsen JE; Datta AN; Gorman KM; King MD; Linhares ND; Burton BK; Paras A; Ellard S; Rankin J; Shukla A; Majethia P; Olson RJ; Muthusamy K; Schimmenti LA; Starnes K; Sedláčková L; Štěrbová K; Vlčková M; Laššuthová P; Jahodová A; Porter BE; Couque N; Colin E; Prouteau C; Collet C; Smol T; Caumes R; Vansenne F; Bisulli F; Licchetta L; Person R; Torti E; McWalter K; Webster R; Gerard EE; Lesca G; Szepetowski P; Scheffer IE; Mefford HC; Carvill GL
Neurology; 2023 Feb; 100(6):e603-e615. PubMed ID: 36307226
[TBL] [Abstract][Full Text] [Related]
19. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
[TBL] [Abstract][Full Text] [Related]
20. De novo GRIN1 mutations: An emerging cause of severe early infantile encephalopathy.
Zehavi Y; Mandel H; Zehavi A; Rashid MA; Straussberg R; Jabur B; Shaag A; Elpeleg O; Spiegel R
Eur J Med Genet; 2017 Jun; 60(6):317-320. PubMed ID: 28389307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
